Social Psychiatry and Psychiatric Epidemiology

, Volume 39, Issue 11, pp 921–926 | Cite as

Double depression in an Australian population

ORIGINAL PAPER

Abstract.

Background:

Double depression, or dysthymia with superimposed major depression, is a major public health issue that imposes considerable burden on the community. Double depression and its associated morbidity have not previously been delineated in an Australian population.

Methods:

A random and representative sample of the South Australian population was assessed by trained interviewers. The mood module of the Primary Care Evaluation of Mental Disorders (PRIME-MD), the Short-Form Health Status Questionnaire (SF-36), and Assessment of Quality of Life (AQoL) instruments were administered, and data related to treatment use and role functioning were collated.

Results:

Double depression was present in 2.2% of the population. This group reported high levels of treatment-seeking behaviour with 90% seeking treatment in the last month and 42.4 % taking antidepressants. They also had a highly significantly poorer quality of life than did others in the community.

Conclusions:

The 2.2% of the population with double depression reported high use of services with poor functioning and health-related quality of life. More effective intervention strategies are required.

Key words

Australia major depression dysthymia double depression quality of life 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Psychiatric Association (2003) Diagnostic and Statistical Manual of Mental Disorders—Fourth edition. Am Psychiatr Assoc, Washington, D. C.Google Scholar
  2. 2.
    Amore M, Jori MC (2001) Faster response on amisulpride 50 mg versus sertraline 50–100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study. Int Clin Psychopharmacol 16:317–324CrossRefPubMedGoogle Scholar
  3. 3.
    Andrews G, Slade T, Issakidis C (2002) Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-being. Br J Psychiatry 181:306–314CrossRefPubMedGoogle Scholar
  4. 4.
    Australian Bureau of Statistics (1995) National health survey: SF-36 population norms, Australia. ABS Catalogue No. 439. Australian Bureau of Statistics, CanberraGoogle Scholar
  5. 5.
    Australian Bureau of Statistics (1998) SEIFA96 (socio-economic indexes for areas), 1996 census of population and housing. ABS Catalogue No. 2033.4. Canberra: Australian Bureau of Statistics, CanberraGoogle Scholar
  6. 6.
    Bebbington P, Hurry J, Tennant C, Sturt E, Wing JK (1981) Epidemiology of mental disorders in Camberwell. Psychol Med 11:561–579PubMedGoogle Scholar
  7. 7.
    Behavioural Epidemiology Unit (1995) South Australian Population Norms for the SF-36. South Australian Health Commission, AdelaideGoogle Scholar
  8. 8.
    Boyer P, Bisserbe J-C, Weiller E (1997) How efficient is a screener? A comparison of the PRIME-MD patient questionnaire with the SDDS-PC screen. Int J Methods Psychiatr Res 7:27–32Google Scholar
  9. 9.
    Cohen J (1992) A power primer. Psychol Bull 112:155–159CrossRefGoogle Scholar
  10. 10.
    Duarte A, Mikkelsen H, Delini-Stula A (1996) Moclobemide versus fluoxetine for double depression: a randomized double-blind study. J Psychiatr Res 30:453–458CrossRefPubMedGoogle Scholar
  11. 11.
    Frances A (1998) Problems in defining clinical significance in epidemiological studies. Arch Gen Psychiatry 55:119CrossRefPubMedGoogle Scholar
  12. 12.
    Goldney R, Fisher L, Wilson D, Cheok F (2000) Major depression and its associated morbidity and quality of life in a random and representative Australian community sample. Aust N Z J Psychiatry 34:1022–1029CrossRefPubMedGoogle Scholar
  13. 13.
    Hawthorne G, Cheok F, Goldney R, Fisher L (2003) The excess cost of depression in South Australia: a population based study. Aust N Z J Psychiatry 37:362–373CrossRefPubMedGoogle Scholar
  14. 14.
    Hawthorne G, Richardson J, Osborne R (1999) The assessment of quality of life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 8:209–224CrossRefPubMedGoogle Scholar
  15. 15.
    Hawthorne G, Richardson J, Osborne R, McNeil H (1997) The assessment of quality of life (AQoL) instrument: construction initial validation and utility scaling. Working Paper 76. Monash University, MelbourneGoogle Scholar
  16. 16.
    Henderson S, Andrews G, Hall W (2000) Australia’s mental health: an overview of the general population survey. Aust N Z J Psychiatry 34:197–205CrossRefPubMedGoogle Scholar
  17. 17.
    Jonas BS, Brody D, Roper M, Narrow WE (2003) Prevalence of mood disorders in a national sample of young American adults. Soc Psychiatry Psychiatr Epidemiol 38:618–624CrossRefPubMedGoogle Scholar
  18. 18.
    Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W et al. (1998) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55:694–700CrossRefPubMedGoogle Scholar
  19. 19.
    Keller MB, Hirschfeld RM, Hanks D (1997) Double depression: A distinctive subtype of unipolar depression. J Affect Disord 45:65–73CrossRefPubMedGoogle Scholar
  20. 20.
    Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfield RM et al. (1992) Time to recovery, chronicity and levels of psychopathology in major depression. Arch Gen Psychiatry 49:809–816PubMedGoogle Scholar
  21. 21.
    Kessler LG, McGonagle KM, Zhao S (1994) Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–20PubMedGoogle Scholar
  22. 22.
    Krupinski J, Stoller A (1971) The Health of a Metropolis. Heineman Educational Australia Pty Ltd, MelbourneGoogle Scholar
  23. 23.
    Lecrubier Y, Boyer P, Turjanski S, Rein W (1997) Amisulpride versus Imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. J Affect Disord 43:95–103CrossRefPubMedGoogle Scholar
  24. 24.
    McCallum J (1995) The SF-36 in an Australian sample: validating a new, generic health status measure. Aust J Public Health 19:160–166PubMedGoogle Scholar
  25. 25.
    Marin DB, Kocsis JH, Frances AJ, Parides M (1994) Desipramine for the treatment of ‘pure’ dysthymia versus ‘double’ depression. Am J Psychiatry 151:1079–1080PubMedGoogle Scholar
  26. 26.
    Mathers CD, Vos ET, Stevenson CE, Begg SJ (2000) The Australian Burden of Disease Study: measuring the loss of health from diseases, injuries and risk factors. Med J Aust 172:592–596PubMedGoogle Scholar
  27. 27.
    Miller IW, Norman WH, Keitner GI (1999) Combined treatment for patients with double depression. Psychother Psychosom 68:180–185CrossRefPubMedGoogle Scholar
  28. 28.
    Murray CJ, Lopez AD (1996) The Global Burden of Disease. World Health Organization and Harvard University Press, GenevaGoogle Scholar
  29. 29.
    Oakley-Browne MA, Joyce PR, Wells JE, Bushnell JA, Hornblow AR (1989) Christchurch psychiatric epidemiology study. Part II: six month and other period prevalences of specific psychiatric disorders. Aust N Z J Psychiatry 23:327–340PubMedGoogle Scholar
  30. 30.
    Ramasubbu R (2002) Treatment of resistant depression by adding noradrenergic agents to Lithium augmentation of SSRIs. Ann Pharmacother 36:634–640CrossRefPubMedGoogle Scholar
  31. 31.
    Regier DA, Farmer ME, Rae DS, Myers JK, Kramer M, Robins LN et al. (1993) One-month prevalence of mental disorders in the United States and socio-demographic characteristics: the Epidemiologic Catchment Area Study. Acta Psychiatr Scand 88:35–47PubMedGoogle Scholar
  32. 32.
    Spitzer RL (1998) Diagnosis and need for treatment are not the same. Arch Gen Psychiatry 55:120CrossRefPubMedGoogle Scholar
  33. 33.
    Spitzer RL, Williams JB, Kroenke K, Linzer M, de Gruy FV, Hahn SR et al. (1994) Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 272:1749–1756CrossRefPubMedGoogle Scholar
  34. 34.
    SPSS Inc. (1993) SPSS for Windows [computer program]. Version 9.0. SPSS Inc, ChicagoGoogle Scholar
  35. 35.
    Taylor AW, Wilson DH, Dal Grande W, Ben-Tovin D, Elzinga RH, Goldney RD et al. (2000) Mental health status of the South Australian population. Aust N Z J Public Health 24:29–34PubMedGoogle Scholar
  36. 36.
    Ware JJ, Kosinski M, Keller SD (1994) SF-36 physical and mental health summary scales: a user’s manual. Health Institute, New England Medical Center, BostonGoogle Scholar
  37. 37.
    Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Bruce ML et al. (1988) Affective disorders in five United States communities. Psychol Med 18:141–153PubMedGoogle Scholar
  38. 38.
    Wells KB, Burnam M, Rogers W, Hays R, Camp P (1992) The course of depression in adult outpatients.Results from the Medical Outcomes Study. Arch Gen Psychiatry 49:788–794PubMedGoogle Scholar
  39. 39.
    Wilson D, Wakefield DM, Taylor A (1992) The South Australian Health Omnibus Survey. Health Promotion Journal of Australia 2:47–49Google Scholar

Copyright information

© Steinkopff Verlag 2004

Authors and Affiliations

  1. 1.Dept. of PsychiatryUniversity of Adelaide, The Adelaide ClinicGilbertonSouth Australia 5081
  2. 2.The Adelaide ClinicGilbertonSouth Australia

Personalised recommendations